Procollagen I Synthesis in Human Skin Fibroblasts: Effect of Culture Conditions on Biosynthesis

Total Page:16

File Type:pdf, Size:1020Kb

Procollagen I Synthesis in Human Skin Fibroblasts: Effect of Culture Conditions on Biosynthesis 0022-202X/ 80/7505-0425$02.00/ 0 THE JOURNAL OF INVESTIGATIVE DERMATOLOGY, 75:425-430, 1980 Vol. 75, No. 5 Copyright © 1980 by The Williams & Wil!Ons Co. Printed in U.S.A. Procollagen I Synthesis in Human Skin Fibroblasts: Effect of Culture Conditions on Biosynthesis HARLEY FREIBERGER, M.D., DAVID GROVE, M.D., ARUNTHATHY SIVARAJAH, B.S., AND SHELDON R. PINNELL, M.D. Division of Dermatology, Department of M edicine, Dulle University Medical Cent e 1~ Durham, North Carolina, U. S.A . Human skin fibroblast culture promises to be a useful and diseased cell lines, we explored cultme conditions, including system for the investigation of the regulation of collagen the concentrations of serum, and ascorbic acid, in an attempt biosynthesis and the study of abnormalities in collagen to understand theii· effects on type-specific procollagen biosyn­ biosynthesis in connective tissue disorders. The effect of thesis. culture conditions on procollagen I biosynthesis has been determined. Optimal conditions for collagen bio­ synthesis were: 10% dialyzed heat-inactivated fetal calf MATERIALS AND METHODS serum, 0.15 mM ascorbate, and 0.078 mM ,8-am.inopro­ pionitrile. Newly synthesized procollagen I accumulated Fibroblast Culture in the medium at a linear rate for 18 hr. Preincubation of Normal human skin fibroblasts (CRL 1225-38-yr-old male, CRL cells in labelling media for 4 hr before adding radioactive 1229-33-yr-old female, CRL 1220- 15-yr-old female) were obtained proline enhanced synthesis. Collagenase digestion was from the American T ype Culture Collection (Rockville, MD) and grown used to study overall collagen biosynthesis. 94% of all in 100 mm plastic Petri dishes (Corning Glass Works, Corning, NY) in cco's modified Eagle medium (DME) containing 1 mg/ mJ glucose synthesized was found in the medium, and 6% Dulbe collagen (Grand Island Biological Co., Grand Island, NY). The medium was in the cell pellet. Under optimal conditions, collagen supplemented with 10% fetal calf serum (Irvine Scientific Sales Com­ comprised 24% of all protein in the medium, and 14% of pany, Fountain Valley, CA) which had been inactivated a t 56 °C for 30 protein produced by the whole culture. min, 50 units/ ml of potassium penicillin G (E.R. Squibb and Sons, Inc., New York, NY) and 50 J.Lg/ ml of streptomycin sulfate (Eli Lilly a nd Company, Indianapolis, IN). The c ultures were incubated at 37°C in Human skin fibroblast culture has proven to be a useful 5% C0 2-95% air atmosphere until confluent. Each experiment was means for studying collagen biosynthesis in inherited connec­ carried out with a single cell line at the same passage number- between tive tissue disorders. Genetic defects are expressed in the cells, 7 and 17. Two days following confluence the c ells were washed with even though they have been removed from their physiological phosphate buffered saline and changed to labeling medi a. Unl ess other­ surroundings. Thus, abnormalities in type-specific collagen syn­ wise noted these media were identical to the growth medium described l calf serum was dialyzed, t he g lucose co n­ thesis have been reported in osteogenesis imperfecta [1] and above e xcept that the feta as 4.5 mg/ ml, and sodium ascorbate 0.05-0.5 mM (Sigma (ecchymotic) [2,3]. Deficient centration w type IV Ehlers-Danlos syndrome Chemical Company, St. Louis, MO) and P-aminopropionitrile fumarate levels of enzymes essential for collagen biosynthesis have been (BAPN) 0.078 mM-0.39 mM (Aldrich Chemical Company, inc., Milwau­ reported in skin fibroblasts: of lysyl hydroxylase in type VI kee, WI) were added. In some experiments 20 mM tricine (Grand Island Ehlers-Danlos syndrome (hydroxylysine-deficient collagen dis­ Biological Co.) or 25 mM Hepes (Sigma) buffers were a dded and the ease) [ 4-7], of procollagen peptidase in type VII Ehlers-Danlos bicarbonate concentration was diminished to 24 mM . Except as other­ syndrome (procollagen peptidase deficiency) [8], and of lysyl wise indicated fibroblasts were preincubated f or 4-24 hr in labeling oxidase in type V Ehlers-Danlos synru·ome (X-linked) [9] and medium and labeled with 3 ml fresh labeling medium containing 25 J.L Ci 3 cutis laxa (X-linked) [10]. 2- 3, H-proline (New England Nuclear, Boston, MA) for an additional h, and Human skin fibroblasts devote a significant portion of theii· 6-72 hr. The medium was harvested, combined wi th cell was ddition of protease inhibitors: 1 mM N-ethyl­ to coll agen [11-14]. Types I and stored at -20°C after a protein synthesizing capacity maleimide (NEM) (Sigma), 1 mM phenylmethylsulfonyl fluoride III procollagen are released into the medium dming culture. (PMSF) (Sigma), and 1 mM disodium ethylenedinitrilotetraacetic acid Although a small amount of procollagen is converted to collagen (EDTA) (Matheson, Coleman, and Bell , Norwood, OH). The ce ll pell et and deposited in fibrillar form in the cell layer, most remains as was harvested with 0.05% trypsin-0.02% EDTA and an aliquot of the procollagen in the medium [15-17]. Each fibroblast seems ca­ cells was counted in a hemocytometer. All results were c orrected f or pable of simultaneously synthesizing both types I and III col­ ceU number. lagen [3]. Since human skin fibroblast cultme promises to be a useful Diethylam.inoethyl (DEAE) Cellulose Column Chromatography tool for studying regulation of collagen biosynthesis in normal Procollagen was isolated by DEAE chromatography modified from Uitto, Lichtenstein, a nd Bauer [18]. Samples were e quilibrated b y dialysis for 18 hr at 4 oc with 70 vol of DEAE buffer ( 2 M m ea, 0.4 mM 1 mM NEM, I mM PMSF, 25 mM Tris HCl, pH 7. 5). (PMSF Manuscript received March 20, 1980; accepted for publication June EDTA, was added in isopropanol at the start of dialysis, and to t he gradient 10, 1980. solution just before chromatography [19]) . Samples were a pplied to a This work was supported by grants from the National Institutes of 1.6 x 5.0 em column of DEAE cellulose (DE52-Whatman; Maids tone Health, grant 2R01 AM 17128 and Cardiology Training grant 5T32 , England). The sample was eluted at 4 °C wi th a 400 mllinear salt HL07101 and by the Howard Hughes Medical Institute Laboratory, the Kent gradient (0-0.2 M NaCI, or in some e xperiments, 0-0.18 M LiCI) in Department of Medicine, at Duke University Medical Center. DEAE buffer, pH 7.5, with the same protease inhibitors, at a fl ow rate This is publication number 52 of the Dermatological Research Lab­ of 100 ml per hr, followed b y a wash of 1 M NaCI in DEAE buffer. 0.5 oratories at Duke University Medical Center. ml aliquots of 5 ml fractions were combined with 3.5 ml of Aquasol-2 Reprint requests to: Sheldon R. Pinnell, M.D., Box 3135 Hospital, (New England Nuclear , Boston, MA) and counted in a P ackard Tri­ ity Medical Center, Durham, NC 27710. Duke Univers Carb liquid scintillation counter at a n effi ciency of 20%. Abbreviations: BAPN: P-aminopropionitrile Pep sinization CMC: carboxymethyl cellulose NEM: N-ethylmaleimide In some cases elution fractions from DEAE column clu-omatography PMSF: phenylmethylsulfonyl fluoride or cell pellets from fibroblast culture were pepsinized in 0.5 M acetic 425 426 FREIBERGER ET AL Vol. 75, No. 5 acid. Pepsin (2720 !L/mg; Worthington Biochemical Corporation, Free­ indistinguishable results. The fraction of co llagenase soluble counts hold, NJ) was employed in a concentration of 50 !Lg/ ml for 6 hr at 4 °C. (cpm) was calculated from the formula: (Collagenase-digested cprn­ Samples were adjusted to pH 7.5 with NaOH and allowed to stand 30 blank cpm)/(Aliquot cpm-blank cpm). Percent collagen in a fraction min at 4°C to insure pepsin inactivation. could be calculated using a rearrangement of the formula of Diegelmann and Peterkosky [22]: % collagen= !:J. cpm/[5.4- (4.4 X !:J. cpm)]. Amino acid analysis was carried out on lyophilized samples of me­ SDS-Polyacrylamide Slab Gel Electrophoresis dium, on procollagen I recovered from DEAE column separations, and on 0.5 N acetic acid-soluble and -insoluble cell pellet fractions. Samples The procedure was modified from Laemmli [20]. DEAE-coiumn were hydrolyzed overnight at 108°C in 6 N HCl under N2; hydrolyzed fractions selected for gel electrophoresis were brought to an ammonium samples were flash-evaporated, then taken up in citrate buffer and sulfate concentration of 176 mg/ml following the addition of carrier resolved on a Beckman model 119 automatic ·amino acid analyzer and lathyritic rat skin collagen (0.2 mg); after centrifugation at 15,000 X g counted. for 30 min, the precipitates were dissolved in a cocktail composed of 3% Neutral protease activity of collagenase and of cell pellets was sodium dodecyl sulfate (SDS), 10% glycerol, 0.01% Bromphenol Blue, assayed with tritium-labeled casein. 20 ,\ labeled casein in phosphate (Fisher Scientific Co., Fairlawn, NJ) and 62.5 mM Tris at pH 6.7. buffer, pH 4, was brought to a final volume of 60 ,\ by addition of Polyacrylamide gel electrophoresis was conducted with 1.5 rom­ collagenase buffer adjusted to yield a fmal collagenase concentration of thick vertical gels [6% acrylamide, (Bio-Rad), 0.44% bis (Bio-Rad)], 11.2 U/ml, and 5 x w-om NEM or 1% albumin. For assay of the cell using a running buffer of 0.02 M glycine, 0.25 mM tris, 0.2% SDS, pH pellet a whole pellet was dialyzed against phosphate buffered saline pH 8.3. Samples containing 5000-10,000 cpm were denatured for 10-15 min 7.4 at 4°C overnight, and a volume equivalent to 80,000 cells employed at 42 °C, with or without 2% ,8-mercaptoethanol, in slab gel cocktail.
Recommended publications
  • Regulation of Procollagen Amino-Propeptide Processing During Mouse Embryogenesis by Specialization of Homologous ADAMTS Protease
    DEVELOPMENT AND DISEASE RESEARCH ARTICLE 1587 Development 133, 1587-1596 (2006) doi:10.1242/dev.02308 Regulation of procollagen amino-propeptide processing during mouse embryogenesis by specialization of homologous ADAMTS proteases: insights on collagen biosynthesis and dermatosparaxis Carine Le Goff1, Robert P. T. Somerville1, Frederic Kesteloot2, Kimerly Powell1, David E. Birk3, Alain C. Colige2 and Suneel S. Apte1,* Mutations in ADAMTS2, a procollagen amino-propeptidase, cause severe skin fragility, designated as dermatosparaxis in animals, and a subtype of the Ehlers-Danlos syndrome (dermatosparactic type or VIIC) in humans. Not all collagen-rich tissues are affected to the same degree, which suggests compensation by the ADAMTS2 homologs ADAMTS3 and ADAMTS14. In situ hybridization of Adamts2, Adamts3 and Adamts14, and of the genes encoding the major fibrillar collagens, Col1a1, Col2a1 and Col3a1, during mouse embryogenesis, demonstrated distinct tissue-specific, overlapping expression patterns of the protease and substrate genes. Adamts3, but not Adamts2 or Adamts14, was co-expressed with Col2a1 in cartilage throughout development, and with Col1a1 in bone and musculotendinous tissues. ADAMTS3 induced procollagen I processing in dermatosparactic fibroblasts, suggesting a role in procollagen I processing during musculoskeletal development. Adamts2, but not Adamts3 or Adamts14, was co-expressed with Col3a1 in many tissues including the lungs and aorta, and Adamts2–/– mice showed widespread defects in procollagen III processing. Adamts2–/– mice had abnormal lungs, characterized by a decreased parenchymal density. However, the aorta and collagen fibrils in the aortic wall appeared normal. Although Adamts14 lacked developmental tissue-specific expression, it was co-expressed with Adamts2 in mature dermis, which possibly explains the presence of some processed skin procollagen in dermatosparaxis.
    [Show full text]
  • Cloning of ADAMTS2 Gene and Colony Formation Effect of ADAMTS2 in Saos-2 Cell Line Under Normal and Hypoxic Conditions, ADYU J SCI, 10(2), 413-426
    Aydogan Türkoğlu & Gültekin Tosun (2020) Cloning of ADAMTS2 Gene and Colony Formation Effect of ADAMTS2 in Saos-2 Cell Line Under Normal and Hypoxic Conditions, ADYU J SCI, 10(2), 413-426 Cloning of ADAMTS2 Gene and Colony Formation Effect of ADAMTS2 in Saos-2 Cell Line Under Normal and Hypoxic Conditions Sümeyye AYDOGAN TÜRKOĞLU1,*, Sinem GÜLTEKİN TOSUN2 1Balıkesir University, Faculty of Science and Literature, Department of Molecular Biology and Genetics, Balıkesir, Turkey [email protected], ORCID: 0000-0003-1754-0700 2Erciyes University, Institute of Health Sciences, Faculty of Veterinary Medicine, Department of Genetics, Kayseri, Turkey [email protected], ORCID: 0000-0002-3927-0089 Received: 03.05.2020 Accepted: 25.09.2020 Published: 30.12.2020 Abstract ADAMTS2 (a disintegrin and metalloproteinase with thrombospondin motifs 2), an N- propeptidase isoenzyme, is an enzyme involved in collagen biosynthesis by providing the amino ends of procollagen to be cut away. ADAMTS2 has anti-angiogenic activity as well as provides the processing of collagen. With this activity, it has become a target in cancer studies. Hypoxic regulation is a process that affects the expression of a large number of genes at the cellular level. Within the scope of our study, the cloning of the ADAMTS2 gene and its expression in Saos-2 (human bone carcinoma) cell line were performed ectopically. For this purpose, the transient transfection of the expression vector containing ADAMTS2 coding sequence was transfected by the calcium-phosphate precipitation method. Recombinant ADAMTS2 mRNA expression was checked by Real-Time PCR in Saos-2 cells. It was observed that there was a 50-fold increase in ADAMTS2 mRNA expression in the transfected Saos-2 cells compared to the control group.
    [Show full text]
  • Review Article
    REVIEW ARTICLE COLLAGEN METABOLISM COLLAGEN METABOLISM Types of Collagen 228 Structure of Collagen Molecules 230 Synthesis and Processing of Procollagen Polypeptides 232 Transcription and Translation 233 Posttranslational Modifications 233 Extracellular Processing of Procollagen and Collagen Fibrillogenesis 240 Functions of Collagen in Connective rissue 243 Collagen Degradation 245 Regulation of the Metabolism of Collagen 246 Heritable Diseases of Collagen 247 Recessive Dermatosparaxis 248 Recessive Forms of EDS 251 EDS VI 251 EDS VII 252 EDS V 252 Lysyl Oxidase Deficiency in the Mouse 253 X-Linked Cutis Laxa 253 Menke's Kinky Hair Syndrome 253 Homocystinuria 254 EDS IV 254 Dominant Forms of EDS 254 Dominant Collagen Packing Defect I 255 Dominant and Recessive Forms of Osteogenesis Imperfecta 258 Dominant and Recessive Forms of Cutis Laxa 258 The Marfan Syndrome 259 Acquired Diseases and Repair Processes Affecting Collagen 259 Acquired Changes in the Types of Collagen Synthesis 260 Acquired Changes in Amounts of Collagen Synthesized 263 Acquired Changes in Hydroxylation of Proline and Lysine 264 Acquired Changes in Collagen Cross-Links 265 Acquired Defects in Collagen Degradation 267 Conclusion 267 Bibliography 267 Collagen Metabolism A Comparison of Diseases of Collagen and Diseases Affecting Collagen Ronald R. Minor, VMD, PhD COLLAGEN CONSTITUTES approximately one third of the body's total protein, and changes in synthesis and/or degradation of colla- gen occur in nearly every disease process. There are also a number of newly described specific diseases of collagen in both man and domestic animals. Thus, an understanding of the synthesis, deposition, and turnover of collagen is important for the pathologist, the clinician, and the basic scientist alike.
    [Show full text]
  • WO 2013/126587 Al 29 August 2013 (29.08.2013) P O P C T
    (12) INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property Organization International Bureau (10) International Publication Number (43) International Publication Date WO 2013/126587 Al 29 August 2013 (29.08.2013) P O P C T (51) International Patent Classification: (74) Agents: MCANDREW, Christopher W. et al; Wilson A61K 38/00 (2006.01) Sonsini Goodrich & Rosati, 650 Page Mill Road, Palo Alto, CA 94304-1050 (US). (21) International Application Number: PCT/US20 13/027 159 (81) Designated States (unless otherwise indicated, for every kind of national protection available): AE, AG, AL, AM, (22) International Filing Date: AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, 2 1 February 2013 (21 .02.2013) BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, (25) Filing Language: English DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, (26) Publication Language: English KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, (30) Priority Data: ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, 61/601,434 2 1 February 2012 (21.02.2012) US NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, 61/726,815 15 November 2012 (15. 11.2012) US RW, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, 61/726,840 15 November 2012 (15. 11.2012) US TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, 61/727,433 16 November 2012 (16.
    [Show full text]
  • Novel Types of Mutation Responsible for the Dermatosparactic Type of Ehlers–Danlos Syndrome (Type VIIC) and Common Polymorphisms in the ADAMTS2 Gene
    View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by Elsevier - Publisher Connector Novel Types of Mutation Responsible for the Dermatosparactic Type of Ehlers–Danlos Syndrome (Type VIIC) and Common Polymorphisms in the ADAMTS2 Gene Alain Colige,à Lieve Nuytinck,w Ingrid Hausser,z Anthonie J. van Essen,y Marc Thiry,z Christian Herens,# Lesley C. Ade` s,Ãà Fransiska Malfait,w Anne De Paepe,w Peter Franck,ww Gerhard Wolff,zz JanC.Oosterwijk,y J. H. Sillevis Smitt,yy Charles M. Lapie` re,à and Betty V. Nusgensà ÃLaboratory of Connective Tissues Biology, GIGA Research Center, University of Lie` ge, Lie` ge, Belgium; wCentrum voor Medische Genetica, Universitair Ziekenhuis, University of Gent, Gent, Belgium; zElectron Microscopic Laboratory, Department of Dermatology, University Heidelberg, Heidelberg, Germany; yDepartment of Clinical Genetics, University Medical Center, Groningen, The Netherlands; zLaboratoire de Biologie cellulaire et tissulaire, University of Lie` ge, Lie` ge, Belgium; #Center for Human Genetics, University of Lie` ge, Lie` ge, Belgium; ÃÃDepartment of Clinical Genetics, The Children’s Hospital at Westmead, and Discipline of Paediatrics and Child Health, University of Sydney, Sydney, Australia; wwDepartment of Pediatrics, University Freiburg, Freiburg, Germany; zzInstitute of Human Genetics and Anthropology, University Freiburg, Freiburg, Germany; yyDepartment of Dermatology, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands Ehlers–Danlos syndrome (EDS) type VIIC, or dermatosparactic type, is a recessively inherited connective tissue disorder characterized, among other symptoms, by an extreme skin fragility resulting from mutations inactivating ADAMTS-2, an enzyme excising the aminopropeptide of procollagens type I, II, and III.
    [Show full text]
  • The Procollagen N-Proteinases ADAMTS2, 3 and 14 in Pathophysiology
    Review The procollagen N-proteinases ADAMTS2, 3 and 14 in pathophysiology Mourad Bekhouche and Alain Colige Laboratory of Connective Tissues Biology, GIGA-R, University of Liège, B-4000 Sart Tilman, Belgium Correspondence to Alain Colige: Laboratory of Connective Tissues Biology, University of Liège, GIGA-Research, Tour de Pathologie B23/3, Avenue de l'Hôpital, 3, B-4000 Sart Tilman, Belgium. [email protected] http://dx.doi.org/10.1016/j.matbio.2015.04.001 Edited by W.C. Parks and S. Apte Abstract Collagen fibers are the main components of most of the extracellular matrices where they provide a structural support to cells, tissues and organs. Fibril-forming procollagens are synthetized as individual chains that associate to form homo- or hetero-trimers. They are characterized by the presence of a central triple helical domain flanked by amino and carboxy propeptides. Although there are some exceptions, these two propeptides have to be proteolytically removed to allow the almost spontaneous assembly of the trimers into collagen fibrils and fibers. While the carboxy-propeptide is mainly cleaved by proteinases from the tolloid family, the amino-propeptide is usually processed by procollagen N-proteinases: ADAMTS2, 3 and 14. This review summarizes the current knowledge concerning this subfamily of ADAMTS enzymes and discusses their potential involvement in physiopathological processes that are not directly linked to fibrillar procollagen processing. © 2015 Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). Introduction determine the cause of dermatosparaxis, a rare genetic disease that appeared in Belgian cattle herds during an Fibrillar collagens are the most abundant proteins inbreeding program [2,3].
    [Show full text]
  • Collagen: a Brief Analysis REVIEW ARTICLE
    OMPJ 10.5005/jp-journals-10037-1143Collagen: A Brief Analysis REVIEW ARTICLE Collagen: A Brief Analysis 1Supriya Sharma, 2Sanjay Dwivedi, 3Shaleen Chandra, 4Akansha Srivastava, 5Pradkshana Vijay ABSTRACT Its adaptable role is due to its immense properties such as 1 Collagen is the most abounding structural protein in a human biocompatibility, biodegradability and easy availability. body representing 30% of its dry weight and is significant to They are centrally involved in the constructions of health because it designates the structure of skin, connective basement membranes along with diverse structures of the tissues, bones, tendons, and cartilage. Much advancement extracellular matrix, fibrillar and microfibrillar networks has been made in demonstrating the structure of collagen triple of the extracellular matrix. It establishes their fundamental helices and the physicochemical premise for their stability. Collagen is the protein molecule which produces the major part fractional monetary unit and identifies crucial steps in of the extracellular matrix. Artificial collagen fibrils that exhibit the biosynthesis and supramolecular preparing of fibril- some characteristics of natural collagen fibrils are now con- lar collagens.3 They are the most abundant structural gregated using chemical synthesis and self-aggregation. The component of the connective tissue and are present in all indigenous collagen fibrils lead further development of artificial multicellular organisms. In the light microscope, collagen collagenous materials for nanotechnology and biomedicine. fibers typically appear as the wavy structure of variable Keywords: Collagen, Structure of Collagen, Diagnostic Impor- width and intermediate length. tance, Collagen Disorders. They stain readily with eosin and other acidic dyes. How to cite this article: Sharma S, Dwivedi S, Chandra S, When examined with a transmission electron micro- Srivastava A, Vijay P.
    [Show full text]
  • Impact of Collagen Alterations on Human Health
    International Journal of Molecular Sciences Review From Structure to Phenotype: Impact of Collagen Alterations on Human Health Lavinia Arseni 1,†, Anita Lombardi 2,† and Donata Orioli 2,* 1 Department of Molecular Genetics, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany; [email protected] 2 Istituto di Genetica Molecolare, Consiglio Nazionale delle Ricerche, 27100 Pavia, Italy; [email protected] * Correspondence: [email protected]; Tel.: +49-0382-546330. † These authors contributed equally to this work. Received: 31 March 2018; Accepted: 4 May 2018; Published: 8 May 2018 Abstract: The extracellular matrix (ECM) is a highly dynamic and heterogeneous structure that plays multiple roles in living organisms. Its integrity and homeostasis are crucial for normal tissue development and organ physiology. Loss or alteration of ECM components turns towards a disease outcome. In this review, we provide a general overview of ECM components with a special focus on collagens, the most abundant and diverse ECM molecules. We discuss the different functions of the ECM including its impact on cell proliferation, migration and differentiation by highlighting the relevance of the bidirectional cross-talk between the matrix and surrounding cells. By systematically reviewing all the hereditary disorders associated to altered collagen structure or resulting in excessive collagen degradation, we point to the functional relevance of the collagen and therefore of the ECM elements for human health. Moreover, the large overlapping spectrum of clinical features of the collagen-related disorders makes in some cases the patient clinical diagnosis very difficult. A better understanding of ECM complexity and molecular mechanisms regulating the expression and functions of the various ECM elements will be fundamental to fully recognize the different clinical entities.
    [Show full text]
  • Novel Types of Mutation Responsible for the Dermatosparactic Type of Ehlers-Danlos Syndrome (Type VIIC) and Common Polymorphisms in the ADAMTS2 Gene
    Published in : The Journal of investigative dermatology (2004) Status: Postprint (Author’s version) Novel Types of Mutation Responsible for the Dermatosparactic Type of Ehlers-Danlos Syndrome (Type VIIC) and Common Polymorphisms in the ADAMTS2 Gene Alain Colige,* Lieve Nuytinck,† Ingrid Hausser,‡ Anthonie J. van Essen,§ Marc Thiry,¶ Christian Herens,# Lesley C. Adès,** Fransiska Malfait,† Anne De Paepe,† Peter Franck,†† Gerhard Wolff,‡‡ Jan C. Oosterwijk,§ J. H. Sillevis Smitt,§§ Charles M. Lapière,* and Betty V. Nusgens* * Laboratory of Connective Tissues Biology, GIGA Research Center, University of Liège, Liège, Belgium; † Centrum voor Medische Genetica, Universitair Ziekenhuis, University of Gent, Gent, Belgium; ‡ Electron Microscopic Laboratory, Department of Dermatology, University Heidelberg, Heidelberg, Germany; § Department of Clinical Genetics, University Medical Center, Groningen, The Netherlands; ¶ Laboratoire de Biologie cellulaire et tissulaire, University of Liège, Liège, Belgium; # Center for Human Genetics, University of Liège, Liège, Belgium; ** Department of Clinical Genetics, The Children's Hospital at Westmead, and Discipline of Paediatrics and Child Health, University of Sydney, Sydney, Australia; †† Department of Pediatrics, University Freiburg, Freiburg, Germany; ‡‡ Institute of Human Genetics and Anthropology, University Freiburg, Freiburg, Germany; §§ Department of Dermatology, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands Abstract Ehlers-Danlos syndrome (EDS) type VIIC, or dermatosparactic
    [Show full text]
  • Insights on ADAMTS Proteases and ADAMTS-Like Proteins from Mammalian Genetics
    Review Insights on ADAMTS proteases and ADAMTS-like proteins from mammalian genetics Johanne Dubail and Suneel S. Apte⁎ Cleveland Clinic Lerner Research Institute, Cleveland, OH, USA Correspondence to Suneel S. Apte: Department of Biomedical Engineering (ND20), Cleveland Clinic Lerner Research Institute, 9500 Euclid Avenue, Cleveland, OH 44195, USA. [email protected] http://dx.doi.org/10.1016/j.matbio.2015.03.001 Edited by R. Iozzo Abstract The mammalian ADAMTS superfamily comprises 19 secreted metalloproteinases and 7 ADAMTS-like proteins, each the product of a distinct gene. Thus far, all appear to be relevant to extracellular matrix function or to cell–matrix interactions. Most ADAMTS functions first emerged from analysis of spontaneous human and animal mutations and genetically engineered animals. The clinical manifestations of Mendelian disorders resulting from mutations in ADAMTS2, ADAMTS10, ADAMTS13, ADAMTS17, ADAMTSL2 and ADAMTSL4 identified essential roles for each gene, but also suggested potential cooperative functions of ADAMTS proteins. These observations were extended by analysis of spontaneous animal mutations, such as in bovine ADAMTS2, canine ADAMTS10, ADAMTS17 and ADAMTSL2 and mouse ADAMTS20. These human and animal disorders are recessive and their manifestations appear to result from a loss-of-function mechanism. Genome-wide analyses have determined an association of some ADAMTS loci such as ADAMTS9 and ADAMTS7, with specific traits and acquired disorders. Analysis of genetically engineered rodent mutations, now achieved for over half the superfamily, has provided novel biological insights and animal models for the respective human genetic disorders and suggested potential candidate genes for related human phenotypes. Engineered mouse mutants have been interbred to generate combinatorial mutants, uncovering cooperative functions of ADAMTS proteins in morphogenesis.
    [Show full text]
  • Diseases of the Collagen Molecule C
    J Clin Pathol: first published as 10.1136/jcp.s3-12.1.82 on 1 January 1978. Downloaded from J. clin. Path., 31, Suppl. (Roy. Coll. Path.), 12, 82-94 Disease mechanisms Diseases of the collagen molecule C. I. LEVENE' From the Department ofPathology, University of Cambridge The title of this paper has been chosen to contrast Table 1 Effect of ,-aminopropionitrile (BAPN) with the term 'collagen diseases' by which Klemperer treatment on the lung collagen content ofsilicotic rats and his colleagues (Klemperer et al., 1942) designated Total (± SD) collagen content the group of diseases that included rheumatoid (mg/lung) arthritis among others. In 1959 the basic lesion in Right Left osteolathyrism-an experimental condition pro- duced in rats or chick embryos by treatment with Normal controls 21-28 ± 1-4 11-95 ± 1-13 Silicotic controls 76-10 ± 18-1 21-86 ± 3-15 the sweet pea seed 'lathyrus factor' (/3-aminopro- Silicotic treatment with BAPN 34-73 ± 1-8 16-75 ± 1-60 pionitrile (BAPN)) and signs that included slipped epiphyses, tendon avulsion, kyphoscoliosis, hernias, and rupture of the aorta-was shown to be a defect in the cross-linking of collagen (Levene and Gross, as the classic example of resolution and epidermis 1959). The mechanism was believed to be the and liver as two examples of regenerating tissues) blocking of aldehyde groups in the collagen molecule examples of the third phase, repair, are numberless. (Levene, 1962) and essential for normal cross-linking The process-organisation-results in scar forma- (Tanzer, 1973; Baileyet al., 1974). Shortly afterwards, tion in such varied conditions as the healing of a Pinnell and Martin (1968) isolated the enzyme re- surgical wound or fractured bone; mitral stenosis, copyright.
    [Show full text]
  • The Ehlers-Danlos Syndromes, Rare Types
    American Journal of Medical Genetics Part C (Seminars in Medical Genetics) 175C:70–115 (2017) RESEARCH REVIEW The Ehlers–Danlos Syndromes, Rare Types ANGELA F. BRADY, SERWET DEMIRDAS, SYLVIE FOURNEL-GIGLEUX, NEETI GHALI, CECILIA GIUNTA, INES KAPFERER-SEEBACHER, TOMOKI KOSHO, ROBERTO MENDOZA-LONDONO, MICHAEL F. POPE, MARIANNE ROHRBACH, TIM VAN DAMME, ANTHONY VANDERSTEEN, CAROLINE VAN MOURIK, NICOL VOERMANS, JOHANNES ZSCHOCKE, AND FRANSISKA MALFAIT * Dr. Angela F. Brady, F.R.C.P., Ph.D., is a Consultant Clinical Geneticist at the North West Thames Regional Genetics Service, London and she has a specialist interest in Ehlers–Danlos Syndrome. She was involved in setting up the UK National EDS Diagnostic Service which was established in 2009 and she has been working in the London part of the service since 2015. Dr. Serwet Demirdas, M.D., Ph.D., is a clinical geneticist in training at the Erasmus Medical Center (Erasmus University in Rotterdam, the Netherlands), where she is involved in the clinical service and research into the TNX deficient type of EDS. Prof. Sylvie Fournel-Gigleux, Pharm.D., Ph.D., is a basic researcher in biochemistry/pharmacology, Research Director at INSERM (Institut National de la Sante et de la Recherche Medicale) and co-head of the MolCelTEG Research Team at UMR 7561 CNRS-Universite de Lorraine. Her group is dedicated to the pathobiology of connective tissue disorders, in particular the Ehlers–Danlos syndromes, and specializes on the molecular and structural basis of glycosaminoglycan synthesis enzyme defects. Dr. Neeti Ghali, M.R.C.P.C.H., M.D., is a Consultant Clinical Geneticist at the North West Thames Regional Genetics Service, London and she has a specialist interest in Ehlers–Danlos Syndrome.
    [Show full text]